Devonian Health Group Inc V.GSD

Alternate Symbol(s): DVHGF

Healthcare Biotechnology

Devonian Health Group Inc. is a clinical-stage pharmaceutical company. It specializes in the development of drugs for various autoimmune inflammatory conditions with novel therapeutic approaches to targeting unmet medical needs. It is developing prescription drugs for the treatment of inflammatory autoimmune diseases, including but not limited to, ulcerative colitis and atopic dermatitis. It is also involved in the development of cosmeceutical products, leveraging the same proprietary approach employed with their pharmaceutical offerings. Its flagship product, Thykamine, is a pharmaceutical product issued from its SUPREX platform, for the prevention and treatment of health problems related to inflammation and oxidative stress, including ulcerative colitis, atopic dermatitis, psoriasis, rheumatoid arthritis, and other autoimmune diseases. Its cosmeceutical products include R-Spinasome and Purgenesis. Its subsidiary, Altius Healthcare Inc., sells prescription pharmaceutical products.

TSXV:GSD - Post by User

Devonian Health Group Inc

<< Previous

Bullboard Posts

Next >>

(1443)
•••

Post by lscfaon Dec 22, 2024 11:31pm

157 Views

Post# 36374540

Q1 f2025 results

No explanation for revenue drop....

Qtr ending	Revenue	Gross profit
Oct 24	5,850,933	1,706,359	29.2%
Jul 24 ye	9,140,248	5,693,974	62.3%
Apr 24	5,125,571	3,873,627	75.6%
Jan 24	2,277,170	1,502,016	66.0%
Oct 23	1,272,520	756,465	59.4%
Jul 23 ye	1,076,169	600,993	55.8%
Apr 23	406,100	265,446	65.4%
Jan 23	452,767	322,991	71.3%
Oct 22	410,358	263,618	64.2%